Literature DB >> 12392126

Women's use of hormone replacement therapy for disease prevention; results of a community survey.

Karen Ballard1.   

Abstract

This study investigated whether an increased use of hormone replacement therapy (HRT) is attributable to a growing motivation among women to use the therapy for disease prevention. Compared with earlier studies, results from this community survey of women aged 51 to 57 years revealed an increased use of HRT, 60% of women had tried HRT, with a median of four years' duration of use. The most frequently cited primacy use for HRT was symptom relief although many women also took the therapy for the prevention of osteoporosis. While women generally commence HRT for symptom relief the extended use of the therapy is, in part, likely to be attributable to an increased motivation among women to remain on HRT for its 'added' benefit of preventing osteoporosis.

Entities:  

Mesh:

Year:  2002        PMID: 12392126      PMCID: PMC1316089     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  9 in total

1.  Social and behavioural influences on the uptake of hormone replacement therapy among younger women.

Authors:  D Kuh; R Hardy; M Wadsworth
Journal:  BJOG       Date:  2000-06       Impact factor: 6.531

2.  Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

Authors:  M J Stampfer; G A Colditz
Journal:  Prev Med       Date:  1991-01       Impact factor: 4.018

3.  Hormone replacement therapy for osteoporosis.

Authors:  F A Pitt; J Brazier
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

4.  Long-term estrogen replacement therapy prevents bone loss and fractures.

Authors:  B Ettinger; H K Genant; C E Cann
Journal:  Ann Intern Med       Date:  1985-03       Impact factor: 25.391

5.  The normal menopause transition.

Authors:  S M McKinlay; D J Brambilla; J G Posner
Journal:  Maturitas       Date:  1992-01       Impact factor: 4.342

6.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

Authors:  M X Tang; D Jacobs; Y Stern; K Marder; P Schofield; B Gurland; H Andrews; R Mayeux
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

7.  Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.

Authors:  F Griffiths; B Convery
Journal:  Br J Gen Pract       Date:  1995-07       Impact factor: 5.386

8.  The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapy.

Authors:  P J Roberts
Journal:  Br J Gen Pract       Date:  1991-10       Impact factor: 5.386

9.  Prevalence and characteristics associated with use of hormone replacement therapy in Britain.

Authors:  T Moorhead; P Hannaford; M Warskyj
Journal:  Br J Obstet Gynaecol       Date:  1997-03
  9 in total
  4 in total

Review 1.  Making decisions about hormone replacement therapy.

Authors:  Janice Rymer; Ruth Wilson; Karen Ballard
Journal:  BMJ       Date:  2003-02-08

2.  Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.

Authors:  Beverley Lawton; Sally Rose; Deborah McLeod; Anthony Dowell
Journal:  BMJ       Date:  2003-10-11

Review 3.  Sex differences and sex steroids in lung health and disease.

Authors:  Elizabeth A Townsend; Virginia M Miller; Y S Prakash
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

4.  Hormone replacement therapy after surgery for stage 1 or 2 cutaneous melanoma.

Authors:  R M MacKie; C A Bray
Journal:  Br J Cancer       Date:  2004-02-23       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.